Insider transactions at Sipai Health Technology Co., Ltd. (HKG:314) show that insiders were net buyers in the past year, with CEO Xuguang Ma making a significant purchase of HK$5.1 million at HK$1.40 per share, higher than the current price of HK$1.30. This indicates an optimistic outlook from insiders despite the company’s losses over the past year. Insiders own 8.3% of the company, suggesting some alignment with shareholders. Overall, while the recent insider buying is promising, caution is advised due to the company’s financial performance.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://simplywall.st/stocks/hk/consumer-retailing/hkg-314/sipai-health-technology-shares/news/this-sipai-health-technology-insider-increased-their-holding
